Active Ingredient History

  • Now
Lixisenatide (trade name Adlyxin) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.   NCATS

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( insulin glargine (toujeo), lixisenatide (adlyxin) - other name: insulin glargine and lixisenatide )
adlyxin | aqve-10010 | ave0010 | ave 0010 | ave-0010 | ave 010 | ave-010 | des-38-proline-exendine-4 (heloderma suspectum)-(1-39)-peptidylpenta-l-lysyl-l-lysinamide | despro38exendin-4(1-39)-lys6-nh2 | iglarlixi | insulin glargine / lixisenatide | l-histidylglycyl-l-α-glutamylglycyl-l-threonyl-l-phenylalanyl-l-threonyl-l-seryl-l-α-aspartyl-l-leucyl-l-seryl-l-lysyl-l-glutaminyl-l-methionyl-l-α-glutamyl-l-α-glutamyl-l-α-glutamyl-l-alanyl-l-valyl-l-arginyl-l-leucyl-l-phenylalanyl-l-isoleucyl-l-α-glutamyl-l-tryptophyl-l-leucyl-l-lysyl-l-asparaginylglycylglycyl-l-prolyl-l-seryl-l-serylglycyl-l-alanyl-l-prolyl-l-prolyl-l-seryl-l-lysyl-l-lysyl-l-lysyl-l-lysyl-l-lysyl-l-lysinamide | lixisenatida | lixisenatide | lixisénatide | lyxumia | zp 10 | zp-10 | zp10a peptide


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue